» Articles » PMID: 31379705

Measurement Properties of the NeuroFlexor Device for Quantifying Neural and Non-neural Components of Wrist Hyper-Resistance in Chronic Stroke

Overview
Journal Front Neurol
Specialty Neurology
Date 2019 Aug 6
PMID 31379705
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Differentiating between the components of wrist hyper-resistance post stroke, i.e., pathological neuromuscular activation ("spasticity") and non-neural biomechanical changes, is important for treatment decisions. This study aimed to assess the reliability and construct validity of an innovative measurement device that quantifies these neural and non-neural components by biomechanical modeling. Forty-six patients with chronic stroke and 30 healthy age-matched subjects were assessed with the NeuroFlexor, a motor-driven device that imposes isokinetic wrist extensions at two controlled velocities (5 and 236°/s). Test-retest reliability was evaluated using intraclass correlation coefficients (ICC) and smallest detectable changes (SDC), and construct validity by testing the difference between patients and healthy subjects and between subgroups of patients stratified by modified Ashworth scale (MAS), and the association with clinical scales. Test-retest reliability was excellent for the neural (NC) and non-neural elastic (EC) components (ICC 0.93 and 0.95, respectively), and good for the viscous component (VC) (ICC 0.84), with SDCs of 10.3, 3.1, and 0.5 N, respectively. NC and EC were significantly higher in patients compared to healthy subjects ( < 0.001). Components gradually increased with MAS category. NC and EC were positively associated with the MAS ( 0.60 and 0.52, respectively; < 0.01), and NC with the Tardieu scale ( 0.36, < 0.05). NC and EC were negatively associated with the Fugl-Meyer Assessment of the upper extremity and action research arm test ( ≤ -0.38, < 0.05). The NeuroFlexor reliably quantifies neural and non-neural components of wrist hyper-resistance in chronic stroke, but is less suitable for clinical evaluation at individual level due to high SDC values. Although construct validity has been demonstrated, further investigation at component level is needed.

Citing Articles

Botulinum Toxin-A High-Dosage Effect on Functional Outcome and Spasticity-Related Pain in Subjects with Stroke.

Intiso D, Centra A, Gravina M, Chiaramonte A, Bartolo M, Di Rienzo F Toxins (Basel). 2023; 15(8).

PMID: 37624266 PMC: 10467116. DOI: 10.3390/toxins15080509.


Measuring resistance to externally induced movement of the wrist joint in chronic stroke patients using an objective hand-held dynamometer.

Mahmoud W, Haugland M, Ramos-Murguialday A, Hultborn H, Ziemann U Clin Neurophysiol Pract. 2023; 8:97-110.

PMID: 37273789 PMC: 10238875. DOI: 10.1016/j.cnp.2023.05.001.


System identification: a feasible, reliable and valid way to quantify upper limb motor impairments.

van de Ruit M, van der Velden L, Onneweer B, Benner J, Haarman C, Ribbers G J Neuroeng Rehabil. 2023; 20(1):67.

PMID: 37231496 PMC: 10210505. DOI: 10.1186/s12984-023-01192-x.


Examining the role of intrinsic and reflexive contributions to ankle joint hyper-resistance treated with botulinum toxin-A.

Vant Veld R, Flux E, VAN Oorschot W, Schouten A, van der Krogt M, van der Kooij H J Neuroeng Rehabil. 2023; 20(1):19.

PMID: 36750869 PMC: 9906865. DOI: 10.1186/s12984-023-01141-8.


Quantitative measurement of resistance force and subsequent attenuation during passive isokinetic extension of the wrist in patients with mild to moderate spasticity after stroke.

Kawamura K, Etoh S, Noma T, Hayashi R, Jonoshita Y, Natsume K J Neuroeng Rehabil. 2022; 19(1):110.

PMID: 36224659 PMC: 9559851. DOI: 10.1186/s12984-022-01087-3.


References
1.
Pandyan A, Johnson G, Price C, Curless R, Barnes M, Rodgers H . A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin Rehabil. 1999; 13(5):373-83. DOI: 10.1191/026921599677595404. View

2.
Fugl-Meyer A, Jaasko L, Leyman I, Olsson S, Steglind S . The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand J Rehabil Med. 1975; 7(1):13-31. View

3.
Gracies J . Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve. 2005; 31(5):535-51. DOI: 10.1002/mus.20284. View

4.
Voerman G, Gregoric M, Hermens H . Neurophysiological methods for the assessment of spasticity: the Hoffmann reflex, the tendon reflex, and the stretch reflex. Disabil Rehabil. 2005; 27(1-2):33-68. DOI: 10.1080/09638280400014600. View

5.
Koo T, Mak A . A neuromusculoskeletal model to simulate the constant angular velocity elbow extension test of spasticity. Med Eng Phys. 2005; 28(1):60-9. DOI: 10.1016/j.medengphy.2005.03.012. View